202 related articles for article (PubMed ID: 7804741)
1. Primary and secondary prevention of arterial thromboembolism.
Verstraete M
Br Med Bull; 1994 Oct; 50(4):946-65. PubMed ID: 7804741
[TBL] [Abstract][Full Text] [Related]
2. Risk factors, interventions and therapeutic agents in the prevention of atherosclerosis-related ischaemic diseases.
Verstraete M
Drugs; 1991; 42 Suppl 5():22-38. PubMed ID: 1726214
[TBL] [Abstract][Full Text] [Related]
3. [Anti-aggregants in 1990].
Verstraete M
Rev Med Interne; 1990; 11(3):209-15. PubMed ID: 2096418
[TBL] [Abstract][Full Text] [Related]
4. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
5. The use of antithrombotic drugs in artery disease.
Gallus AS
Clin Haematol; 1986 May; 15(2):509-59. PubMed ID: 3524934
[TBL] [Abstract][Full Text] [Related]
6. The role of antiplatelet therapy in acute coronary syndromes and for secondary prevention following a myocardial infarction.
Jafri SM; Zarowitz B; Goldstein S; Lesch M
Prog Cardiovasc Dis; 1993; 36(1):75-83. PubMed ID: 8321905
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic treatment of cerebrovascular disease.
Oczkowski WJ; Turpie AG
Baillieres Clin Haematol; 1990 Jul; 3(3):781-813. PubMed ID: 2271790
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic drugs for older subjects. Guidelines formulated jointly by the Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG).
Di Minno G; Tufano A; Cerbone AM
Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):41-62. PubMed ID: 11383324
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
Aronow WS
Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
[TBL] [Abstract][Full Text] [Related]
11. The use of antithrombotic drugs in older people.
Tufano A; Cerbone AM; Di Minno G
Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet agents and anticoagulants for hypertension.
Lip GY; Felmeden DC
Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
[TBL] [Abstract][Full Text] [Related]
13. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Tran H; Anand SS
JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
[TBL] [Abstract][Full Text] [Related]
14. Are agents affecting platelet functions clinically useful?
Verstraete M
Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
[TBL] [Abstract][Full Text] [Related]
16. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2006 Apr; (2):CD001820. PubMed ID: 16625549
[TBL] [Abstract][Full Text] [Related]
17. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684
[TBL] [Abstract][Full Text] [Related]
18. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
Arjomand H; Cohen M; Ezekowitz MD
J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Harker LA
Circulation; 1986 Feb; 73(2):206-23. PubMed ID: 3510760
[TBL] [Abstract][Full Text] [Related]
20. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
